Work

64609 Safety and tolerability of tirbanibulin for the treatment of actinic keratosis (AK): Results from clinical trials and post-registration

Year: 2025

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2025.05.1164

Authors: Andrew Blauvelt, Mark Lebwohl, Todd Schlesinger, Carola Berking, Andrea Conti, Edward Lain, George Martin, Yolanda Gilaberte, Raidah Salem, Paul Tomondy, Neal Bhatia

Institutions: Oregon Medical Research Center, Icahn School of Medicine at Mount Sinai, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Ospedale Infermi di Rimini, Universidad de Zaragoza, Hospital Universitario Miguel Servet, Therapeutics Clinical Research

Language: English

Topic: Nonmelanoma Skin Cancer Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413881717

FWCI:

Cites:

Cited by:

Related to: 10